GUIDELINES for the treatment of people with or at risk for sexually transmitted infections (STIs) have been updated, according to a report published in the July 23 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Kimberly A. Workowski, M.D., from the CDC in Atlanta, and colleagues updated guidelines for treatment of persons who have or are at risk for STIs following consultation with professionals knowledgeable in the field of STIs.
The guidelines provide updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis. For pelvic inflammatory disease, metronidazole was added to the recommended treatment regimen.
For bacterial vaginosis, recommended regimens include oral metronidazole, metronidazole gel, or clindamycin cream, and alternative regimens include oral clindamycin, clindamycin ovules, secnidazole, and tinidazole.
Recommendations were updated for Mycoplasma genitalium management, with recommended regimens varying if resistance testing is or is not
You’ve reached your free article limit
Subscribe to enjoy unlimited access to trusted journalism. Cancel anytime.
Subscribe nowNeed help? molokom@insidepolitic.co.za
